Emily Melton

“This is validation for the movement we’re leading to provide women better healthcare,” - Joanna Strober, co-founder and chief executive of Midi Health. Women's telehealth company Midi Health has raised $100 million in a Series D funding round, valuing the women’s telehealth company at more than $1 billion and cementing its status as a unicorn. The round was led by Goodwater Capital, with new backing from Foresite Capital and Serena Ventures, alongside existing investors including GV (Google Ventures), @Emerson Collective, McKesson Ventures, Felicis Ventures, AVP | Advance Venture Partners and SemperVirens VC. The funding marks one of the largest recent raises in women’s digital health. https://lnkd.in/eiUaVJai

55

2 Comments

New blog out for Pave Health Ventures! If you’re a startup tackling health-related challenges, take a closer look at the intersection of two massive, fast-growing industries: Consumer Health & Wellness and Traditional Healthcare. You might be pleasantly surprised. The opportunity is bigger (and closer) than you think. Read the full blog + subscribe to our Substack for more insights at the intersection of wellness and healthcare: https://lnkd.in/gJ2T6WBK

15

1 Comment

Say you know me without saying it ... "Hey, let's improve healthcare purchasing!" Durable goods, every day disposables, every part of purchasing in healthcare products continues to be broken. Natan Wise and team Conduit Health are improving the spend process for consumers, healthcare providers. This moves $100b in annual spend, but also improves people's lives. You can read our deeper take at XYZ here: https://lnkd.in/gEhfACtB Thrilled to have more money to run with the Drive Capital partnership! And Maybe you want to improve people's everyday lives? Live in NYC? You probably want to work here: https://lnkd.in/gtGEB8Ku

26

1 Comment

🚨 Big news from the frontlines of healthcare innovation: Ellipsis Health just announced a $45M funding round led by Salesforce Ventures, Khosla Ventures, and CVS Health Ventures—and it’s making headlines in the Wall Street Journal. We’ve been proud backers of Ellipsis Health at E12 Ventures because they’ve taken a bold, contrarian approach: instead of chasing efficiency at the cost of patient experience, they’ve built an emotionally intelligent AI that brings humanity back to healthcare. Meet Sage — the AI Care Manager trained on millions of real clinical conversations and powered by Ellipsis’ proprietary Empathy Engine. It delivers 24/7 support to patients with complex needs — the same patients who typically slip through the cracks because of capacity constraints and staffing shortages. This is a huge leap forward. Instead of forcing trade-offs between quality and scale, Sage shows we can have both. It’s not just automating workflows — it’s reimagining what scalable, empathetic care looks like. Strategic investors across the ecosystem — payers (CVS), platforms (Salesforce), and deep tech VCs (Khosla) — all recognize the same thing: emotionally intelligent AI is the next frontier in healthcare. Congrats to the Ellipsis team — thrilled to be on this journey with you. #AI #HealthcareInnovation #EllipsisHealth #EmpathyEngine #VentureCapital #DigitalHealth #E12Ventures https://lnkd.in/giVckKyq

46

4 Comments

🚨 MIDI HEALTH HITS $1 BILLION VALUATION 🚨 Midi Health has become the latest women’s health unicorn, reaching a $1 billion valuation following a $100 million Series D round led by Goodwater Capital💰. Founded by Joanna Strober, Midi began as a telehealth platform focused on menopause care and is now expanding into weight loss and branded supplements. Crucially, the ambition is clear: to build the biggest consumer brand in women’s health 🌍 For those of us in life sciences executive search, this moment matters 👇 It reflects a broader shift in the market: • Women’s health moving from underserved to investable at scale 📈 • Consumer-first healthcare brands becoming credible category leaders 🏆 • Founder-led vision shaping businesses built for long-term impact, not quick exits 🚀 Midi has now raised $250 million in total funding. Strober has been clear she is not looking to sell. Instead, she is focused on building something truly large and, in doing so, inspiring more women to build and lead ambitious companies ✨👩‍💼 As investors, boards and leadership teams look ahead, this is a powerful reminder that representation at the top shapes entire markets 💡 #WomensHealth #FemaleFounders #Leadership #LifeSciences #HealthTech #ConsumerHealth #ExecutiveSearch #WomenInLeadership #LuminaryGroup

10

🔥🔥 PANEL ALERT 🔥🔥 What gaps may AI fill with the recent policy impacts on Medicaid?  Coyote Ventures 2025 Health Equity Innovators Fall Gathering will feature an expert panel discussing the impact of AI in Healthcare with a particular focus on its implications for Medicaid and Medi-Cal. As we are past the mid-point mark of 2025, AI and OBBBA are reshaping U.S. health policy in profound ways, from expansive new federal and state guidelines to sharp debates around oversight and authority. Our discussion will dive into the themes of bias, equity, and accountability in AI, and what these evolving mandates mean for those developing, deploying, or relying on AI-driven solutions in healthcare. With Medicaid and Medi-Cal covering some of our most vulnerable populations, the stakes couldn’t be higher. I’m looking forward to an engaging conversation with Priyanka Vaidya, Pooja Mittal, and Stella Tran - exploring how we can ensure AI not only advances innovation but also builds trust, fairness, and better outcomes. Curious to hear your thoughts: can AI truly help reduce disparities in Medicaid care, or will it deepen them?

63

6 Comments

Andreessen Horowitz is one of the world’s most influential venture capital firms Partners David Haber, Julie Yoo, and Daisy Wolf describe companies operating at the intersection of fintech and healthtech as "payvidors"—businesses that not only deliver care but also solve the question of how patients and providers pay for it.This thinking sits at the very center of HealthCap Africa’s investment thesis. We focus on healthtech and fintech because we see, every day, that healthcare delivery is meaningless without the ability to pay for it. A diagnostic lab, a hospital, or a telehealth platform can only scale sustainably when patients have access to financial tools—insurance, credit, payments, or savings—that make care affordable and accessible. That is why our team combines deep subject-matter expertise across both sectors. We back the entrepreneurs building at this frontier: health innovators who improve quality of care, and fintech disruptors who unlock access to it. Together, these companies create the infrastructure for healthier, longer lives across Africa and beyond. 📖 Read David Haber and his team’s excellent piece on payvidors here: https://lnkd.in/dvMJ_KtZ

32

4 Comments

If you’re building a health tech startup, here’s a useful perspective from the accelerator side. At ViVE, I spoke with Keith Camhi, Managing Director of the Techstars Healthcare Accelerator powered by Permanente Medicine Mid-Atlantic States. The program invests in early-stage startups and helps founders run pilots with physicians in the Kaiser Permanente ecosystem. Some interesting takeaways: • Techstars still prioritizes “Team, team, team” above everything else; • Founders in the program are interviewed by physicians before acceptance; • The goal isn’t just mentorship — it’s getting real pilots with providers; • AI startups dominate applications, but the focus remains on real clinical problems. Applications for the next cohort open soon, so founders may want to keep an eye on it. Short interview from #ViVE 👇 🎥 Watch here: https://lnkd.in/gNN_5628 #Vive2026 #digitalhealthinsideout #health2tech #digitalhealth

41

1 Comment

Talkiatry just secured $130M in Series D funding, and if you think this is just another telehealth headline drifting through your feed, slow down for a second. This is mental health infrastructure getting capitalized like it matters. Andreessen Horowitz and Perceptive Advisors led the round, with support from Left Lane Capital and blisce/, plus debt financing from Banc of California. That is not tourist money. That is long-term conviction capital backing a model that is built to last. Respect where it is due. Congratulations to Robert Krayn, Co-Founder and CEO, and Georgia Gaveras, DO, DO, Co-Founder and CMO. Building a national psychiatry practice is not for the faint of heart. It is regulated, clinician-constrained, payer-entangled, and emotionally charged. The easy route was another marketplace. Talkiatry chose the harder road and built a full-stack, in-network practice employing psychiatrists and therapists as W-2 clinicians. Talkiatry launched in 2020 out of New York City with a simple but sharp thesis: serious mental health care requires serious alignment. Not gig work. Not random referrals. Real doctors, employed, accountable, measured. Fast forward and the company operates across 43 states with more than 300 psychiatrists, working inside national insurance contracts that cover over 200M lives. In a world where out-of-network bills feel like jump scares, Talkiatry leaned into being in-network. They did not chase vanity growth. They built payor relationships. They invested in measurement-based and value-based care. They made access less of a luxury item and more of a standard benefit. The name says it all. Talk-iatry. Conversation meets clinical rigor. Not just talk therapy, but psychiatry with teeth. Diagnosis, medication management, structured care pathways. The kind of platform that understands the difference between feeling off and being clinically depressed, and treats both with respect. So what does $130M really signal? It says the market believes behavioral health is not a side quest. It is core infrastructure. It says investors see a physician-led model that can scale without losing its soul. It says there is room for companies that respect both the clinician and the balance sheet. For founders watching this from the sidelines, there is a lesson hiding in plain sight. Pick the hard model if it creates durable alignment. Build with regulators and payors in mind from day 1. Hire operators who understand that healthcare is a marathon run in steel-toe boots. #MentalHealth #BehavioralHealth #HealthcareInfrastructure #ValueBasedCare #DCTalks

4

1 Comment

𝗦𝘂𝗽𝗲𝗿𝗗𝗶𝗮𝗹 𝗥𝗮𝗶𝘀𝗲𝘀 $𝟭𝟱𝗠 𝘁𝗼 𝗙𝗶𝘅 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲’𝘀 𝗠𝗼𝘀𝘁 𝗔𝗻𝗻𝗼𝘆𝗶𝗻𝗴 𝗕𝗼𝘁𝘁𝗹𝗲𝗻𝗲𝗰𝗸: 𝗧𝗵𝗲 𝗣𝗵𝗼𝗻𝗲 𝗖𝗮𝗹𝗹 SuperDial, the AI-powered healthtech startup, just closed 𝗮 $𝟭𝟱 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗦𝗲𝗿𝗶𝗲𝘀 𝗔 𝗿𝗼𝘂𝗻𝗱 led by SignalFire, with backing from Slow Ventures, BoxGroup, and Scrub Capital. Founded by Sam Schwager and Harrison Caruthers, SuperDial is tackling one of healthcare’s most painful inefficiencies—manual, phone-based billing workflows. Its AI voice platform automates calls for insurance verifications, prior authorizations, and claim follow-ups—cutting delays, reducing staff burnout, and speeding up patient reimbursements. The funding will fuel platform expansion, deeper EHR/payor integrations, and audit-grade reliability—transforming revenue cycle ops into a self-driving engine for providers. SuperDial | Sam Schwager | Harrison Caruthers | SignalFire | Slow Ventures BoxGroup | Scrub Capital | UNI NETWORK GROUP #SuperDial #HealthTech #AIVoicePlatform #RevenueCycleAutomation #AIHealthcare #SeriesAFunding #DigitalHealth #StartupFunding #HealthcareInnovation #UniNetwork

1

What drew us to Arya Health wasn’t just the technology, but the clarity of purpose behind it. Kunal and Arunram are solving one of the hardest and least glamorous problems in healthcare: the broken labor operations that keep post-acute care running. This is a $500B+ market, nearly 10% of U.S. healthcare spend, yet most of it still depends on manual coordination. Every day, agencies are juggling thousands of nurses, last-minute shift cancellations, credential expirations, and payroll calculations across dozens of systems. The administrative burden is crushing, and it’s only getting worse as the population ages and demand for home-based care accelerates. Arya has built AI agents that act as a true digital workforce for healthcare operations - autonomously handling scheduling, onboarding, compliance tracking, and payroll. Their scheduling agent alone manages complex variables like patient needs, clinical fit, distance, and bonus pay, continuously rebalancing assignments in real time. The early traction has been remarkable. Customers whom we talked to consistently describe Arya as transformational - “what they’ve always dreamed of” and a product that will “forever change the industry.” Agencies are already seeing utilization rise from roughly 60% to over 80%, driving significant improvements in coverage, patient outcomes, and operating margins. What stands out most about Kunal and Arun is how deeply they care about the people behind these operations. They spend time in the field with schedulers, caregivers, and agency leaders - the unsung heroes who hold the healthcare system together - and they build with empathy and urgency. That care shows up in the product and in every customer relationship. At ACME Capital, we believe the most impactful AI companies will rebuild critical industries from the inside out. Nurses, home health aides, and post-acute caregivers are the backbone of our healthcare system, and often the backbone of their communities. Arya Health is giving them the modern infrastructure they deserve. Congratulations to Kunal, Arun, and the entire Arya team on your oversubscribed $18.2M Series A. We’re proud to lead this round and partner with you as you reimagine how care gets delivered across homes and communities.

23

Morgan asks the $1TN question: As a healthcare CEO, can you trust OpenAI or Anthropic as your AI one-stop-shop? On the ground implementing AI at healthcare enterprises, the answer is nuanced. It's a trade-off between 2 options: 1. Self-hosted ("Control"): Data security, vendor flexibility, more customizable, more workflow control, but higher maintenance costs. 2. SaaS/API ("Convenience"): SOTA models, built-in best practices, potentially higher availability via SLA, but less workflow control and lower maintenance costs. A hybrid option is emerging: managed AI/automation where you control infrastructure, data, and integration with help from a managed intelligence provider, while the model vendor handles upgrades. AI model companies would be wise to lean into this option. Ultimately it comes down to data security and workflow control. ERP and SaaS cycles taught us that "out of the box best-practice" workflows don't work at enterprise scale without massive customization. AI that learns may ease some of this, but not all. We'll need headless automation that decouples AI models from workflow. (Disclaimer: My own professional opinion, not that of any of our healthcare clients or their PE funds) #AI #healthcare #enterpriseAI

5

There's a new question in every health tech buying cycle that didn't exist 18 months ago: "Is this already on the roadmap of our foundation model vendor?" As we discussed in our 2026 healthcare predictions, we are entering a moment where the end user, clinicians and operators included, can increasingly build software themselves using agentic coding environments. In practice, this shows up when a CIO asks whether a proposed point solution is meaningfully different from what their existing foundation model could deliver with internal prompts, guardrails, and a few weeks of engineering time. This shift is quietly reshaping the competitive calculus. Startups selling into healthcare enterprises no longer compete only with the EHR vendor’s roadmap. They also compete with what a foundation model provider can plausibly ship for that customer, often faster and at lower marginal cost. Importantly, while the moat around building software is eroding, the moat around running software in healthcare is not. Healthcare enterprises are not set up to independently handle deep workflow integration, continuous iteration, reliability at scale, and governance across clinical, legal, and regulatory dimensions. That operational gap is where durable companies are still built. We expect this dynamic to introduce real friction into buying cycles for point solutions with thin moats. At the same time, it expands opportunity for companies with defensible data assets, deep workflow entrenchment, and true platform potential. Artera and Atropos Health are two strong examples from Breyer Capital's portfolio, both highlighted in the article. Special thanks to Brian Gormley for featuring our perspective in today's The Wall Street Journal piece on OpenAI and Anthropic's entry into healthcare. Jim Breyer Daniel Breyer Andre Esteva, PhD Brigham Hyde

281

29 Comments

When the FDA sends dozens of questions and every hour counts, Weave now automates that exact moment. The launch of HAQ Manager — co-developed with a top-20 pharma company — marks another step in expanding a proven AI platform that already cuts IND timelines by 50%+. From proven ompact to platform xxpansion Weave’s technology has already cut IND timelines by 50%+, and now it’s expanding that proven capability with the launch of HAQ Manager, built in collaboration with Takeda. When the FDA sends dozens of questions and every hour counts, Weave now automates that exact moment. This isn’t just a product launch—it’s systematic expansion across the regulatory lifecycle. Congrats to the Weave team on this launch. #healthtech #innovation #regulatory #HAQ #WeaveBio

18

I’m excited to share that Angle Health, founded by former Palantir Technologies execs Tylon (Ty) W. and Anirban Gangopadhyay, has announced an oversubscribed Series B bringing total funding to nearly $200M. I’m proud to be an early investor and to have led this competitive round with the amazing team at Portage. Why we keep leaning in: - 26x revenue growth since the Series A - Serving 3,000+ employers across 44 states - 80%+ renewal rates Angle Health is rebuilding the healthcare benefits infrastructure for SMBs, who employ nearly half of America’s workforce but have historically been shut out of enterprise-grade coverage. Their AI-native platform helps predict risk and deliver better care at a sustainable cost. This is exactly the kind of product-driven, AI-native company we’re proud to support at Mighty Capital.

38

Arya Health raises $18.2M Series A to automate post-acute care operations with #AI New York–based Arya Health has raised $18.2 million in Series A funding, led by ACME Capital, with participation from Ridge Ventures, Twelve Below, #OpenAI executives, and post-acute care providers — bringing its total funding to $25 million. Founded by Kunal Sarda, Arya Health is building AI-powered digital agents to automate scheduling, compliance tracking, and other administrative workflows in home health and post-acute care. The company plans to use the funds to expand its product suite, scale hiring, and further reduce the administrative burden for caregivers — allowing them to focus more on patients. Arunram K.  - CTO & Co-Founder at Arya Julien Mermelstein - Head of Growth @ Arya Rohan Deuskar  - Angel Investor Anand Chandrasekaran- Principal Engineer @ Arya #FundingNews #HealthTech #AIinHealthcare #PostAcuteCare #Automation #SeriesA #AryaHealth #AIFundingUpdates #AITechSupports

1

Has any Digital Health company in history hit 2M lives in 3 years or less in market? "You have to establish trust."↗↗↗↗ Hear Elan Adler 🩻 CEO and Founder of OneImaging walk us through their explosive growth over the last 3 years. Learn all about their mission, impact, how they help employees, while also saying money for employers! 💥 "It went from outbound, to getting inbound." Watch Here: https://lnkd.in/d5AnVx8n Listen here: https://lnkd.in/ga_TNNnZ

19